Termination Agreements in the Pharmaceuticals Industry

136 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Acer Therapeutics Inc. (3)
ACHILLION PHARMACEUTICALS INC (1)
Adamis Pharmaceuticals Corp (1)
ADIAL PHARMACEUTICALS, INC. (1)
Allergan, plc (1)
Altus Pharmaceuticals Inc. (2)
Amag Pharmaceuticals (3)
Ampio Pharmaceuticals, Inc. (1)
AMYLIN PHARMACEUTICALS INC (1)
ANGIOTECH PHARMACEUTICALS INC (1)
ANI Pharma Inc (2)
APRICUS BIOSCIENCES, INC. (2)
Assertio Therapeutics, Inc (2)
ATAI Life Sciences B.V. (1)
AUXILIUM PHARMACEUTICALS INC (1)
AVADEL PHARMACEUTICALS PLC (1)
AVANIR PHARMACEUTICALS, INC. (1)
AXIM BIOTECHNOLOGIES, INC. (1)
AYTU BIOSCIENCE, INC (3)
Bespoke Extracts, Inc. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (2)
Bohai Pharmaceuticals Group, Inc. (1)
Bristol-Myers Squibb (1)
CADENCE PHARMACEUTICALS INC (2)
CASSAVA SCIENCES INC (1)
Catalent Inc (1)
Celator Pharmaceuticals Inc (1)
Cocrystal Pharma, Inc. (1)
Columbia Care Inc. (1)
Context Therapeutics Inc. (1)
Cronos Group Inc. (2)
ELITE PHARMACEUTICALS INC (1)
ENCYSIVE PHARMACEUTICALS INC (3)
Exactus, Inc. (1)
EYENOVIA, INC. (1)
FERMAVIR PHARMACEUTICALS, INC. (2)
Foamix Pharmaceuticals Ltd. (2)
GB SCIENCES INC (1)
HARROW HEALTH, INC. (2)
IDENIX PHARMACEUTICALS INC (1)
Innoviva, Inc. (2)
Intra-Cellular Therapies, Inc. (1)
Jaguar Health, Inc. (3)
Jazz Pharmaceuticals plc (1)
JUNIPER PHARMACEUTICALS INC (1)
Kedem Pharmaceuticals Inc. (1)
KING PHARMACEUTICALS INC (1)
Level Brands, Inc. (1)
Luckwel Pharmaceuticals Inc. (2)
Melt Pharmaceuticals, Inc. (1)
Menlo Therapeutics Inc. (1)
Merck (1)
MJ Holdings, Inc. (5)
MYnd Analytics, Inc. (2)
MyoKardia Inc (1)
NEKTAR THERAPEUTICS (1)
NewBridge Global Ventures, Inc. (1)
Notis Global, Inc. (1)
NovaBay Pharmaceuticals, Inc. (1)
NOVEN PHARMACEUTICALS INC (1)
NUCRYST Pharmaceuticals Corp. (1)
NURX PHARMACEUTICALS, INC. (1)
Onconova Therapeutics, Inc. (1)
ORAMED PHARMACEUTICALS INC. (1)
OSCIENT PHARMACEUTICALS CORP (1)
Paratek Pharmaceuticals, Inc. (2)
PENWEST PHARMACEUTICALS CO (2)
Perrigo (1)
Pfizer (1)
PLAYERS NETWORK (1)
PLIANT THERAPEUTICS, INC. (1)
PLx Pharma Inc. (1)
ProPhase Labs, Inc. (3)
QUESTCOR PHARMACEUTICALS INC (1)
REATA PHARMACEUTICALS INC (1)
Revance Therapeutics, Inc. (2)
Roivant Sciences Ltd. (1)
SALIX PHARMACEUTICALS LTD (2)
SCYNEXIS INC (7)
Sucampo Pharmaceuticals, Inc. (1)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
TEVA PHARMACEUTICAL INDUSTRIES LTD (2)
Theravance Biopharma, Inc. (1)
TIBET PHARMACEUTICALS, INC. (1)
Tongli Pharmaceuticals (USA), Inc. (2)
Trubion Pharmaceuticals, Inc (1)
Valera Pharmaceuticals Inc (4)
VIVUS INC (1)
XCEL PHARMACEUTICALS INC (1)
ZOGENIX, INC. (1)
Zynerba Pharmaceuticals, Inc. (1)

Recent Contracts

Mutual Termination and Reassignment, dated January 12, 2024, by and between Eyenovia, Inc and Bausch + Lomb Ireland Limited (EYENOVIA, INC., Filed With SEC on March 18, 2024)
Notice of Termination of Purchase and Sale Agreement between ANI Pharmaceuticals Canada Inc. and Mastercom Inc (ANI Pharma Inc, Filed With SEC on February 29, 2024)
Termination Agreement, dated as of December 28, 2023, by and between Catalent Pharma Solutions GmbH and Manja Boerman (Catalent Inc, Filed With SEC on February 14, 2024)
Termination and New Consultancy Agreement, by and among the Company, ATAI AG and Christian Angermayer, dated January 7, 2024 (ATAI Life Sciences B.V., Filed With SEC on January 9, 2024)
Third Amendment to Termination and License Agreement" b/w Company and Merck Sharp & Dohme Corp. (Merck), dated January 5, 2018 (SCYNEXIS INC, Filed With SEC on November 13, 2023)
Second Amendment to Termination and License Agreement" b/w the Company and Merck Sharp & Dohme (SCYNEXIS INC, Filed With SEC on November 13, 2023)
Amendment to Termination and License Agreement, dated December 3, 2014, between SCYNEXIS, Inc. and Merck Sharp & Dohme Corp (SCYNEXIS INC, Filed With SEC on November 13, 2023)
Termination Agreement by and between Healthpeak OP, LLC and the Company, dated September 28, 2023 (PLIANT THERAPEUTICS, INC., Filed With SEC on October 3, 2023)
Mutual Termination and Release Agreement, dated September 21, 2023, by and between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc (ORAMED PHARMACEUTICALS INC., Filed With SEC on September 26, 2023)
Termination Agreement dated as of August 28, 2023 by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AB (Acer Therapeutics Inc., Filed With SEC on August 31, 2023)
Amended and Restated Termination of Expansion Agreements dated October 15, 2019, by and between TC Legacy Land Venture LLC, and Reata Pharmaceuticals, Inc (REATA PHARMACEUTICALS INC, Filed With SEC on August 8, 2023)
Termination Agreement, dated July 31, 2023, between Cresco Labs Inc. and Columbia Care Inc (Columbia Care Inc., Filed With SEC on August 3, 2023)
Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (AYTU BIOSCIENCE, INC, Filed With SEC on May 11, 2023)
Termination Agreement of the Clinical Trial Collaboration and Supply Agreement, dated March 21, 2023 between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group (Context Therapeutics Inc., Filed With SEC on March 22, 2023)
Mutual Termination of License Agreement, dated as of January 31, 2023, by and among Jaguar Health, Inc., SynWorld Technologies Corporation, C&E Telecom, LTD, and Tao Wang (Jaguar Health, Inc., Filed With SEC on February 6, 2023)
Termination Agreement dated as of January 30, 2023 among Acer Therapeutics Inc., the Lenders party thereto and MAM Aardvark, LLC, not individually, but solely in its capacity as... (Acer Therapeutics Inc., Filed With SEC on January 31, 2023)
Termination Agreement (Bespoke Extracts, Inc., Filed With SEC on November 21, 2022)
Partial Termination and Supplementary Fee Agreement relating to the Clinical Supply Agreement and Commercial Supply Agreement, dated as of July 25, 2022, by and between... (Roivant Sciences Ltd., Filed With SEC on November 14, 2022)
Mutual Termination Agreement, dated October 7, 2022 between ImprimisRx and EyePoint Pharmaceuticals, Inc (HARROW HEALTH, INC., Filed With SEC on November 14, 2022)
Letter of Termination and Release Agreement, dated May 28, 2021, by and between the Registrant and Mark Hazard (Melt Pharmaceuticals, Inc., Filed With SEC on September 21, 2022)
Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (AYTU BIOSCIENCE, INC, Filed With SEC on May 16, 2022)
Termination Agreement dated March 3, 2022, by and between AXIM Biotechnologies, Inc. and Empowered Diagnostics, LLC (AXIM BIOTECHNOLOGIES, INC., Filed With SEC on April 15, 2022)
Termination Agreement dated August 26, 2021 (MJ Holdings, Inc., Filed With SEC on October 7, 2021)
Termination Agreement, dated June 29, 2021 by and between Aytu BioPharma, Inc. and Avrio Genetics, LLC (AYTU BIOSCIENCE, INC, Filed With SEC on September 28, 2021)
Acknowledgment and Termination Agreement, dated as of June 14, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (APRICUS BIOSCIENCES, INC., Filed With SEC on June 17, 2021)
Termination Agreement between the Company, Blue Sky Companies, LLC and Lets Roll Nevada, LLC dated March 24, 2021 (MJ Holdings, Inc., Filed With SEC on April 15, 2021)
Fourth Amendment to Termination and License Agreement between SCYNEXIS, Inc. and Merck Sharp & Dohme Corp. dated December 2, 2020 (SCYNEXIS INC, Filed With SEC on March 29, 2021)
Termination Agreement dated March 2, 2021 (PLx Pharma Inc., Filed With SEC on March 2, 2021)
Notice of Termination dated January 21, 2021 (MJ Holdings, Inc., Filed With SEC on January 27, 2021)
Amendment and Termination Agreement, dated and effective as of January 14, 2021 (ProPhase Labs, Inc., Filed With SEC on January 15, 2021)
Termination and Mutual Release Agreement between MJ Holdings, Inc. and Healthier Choices Management Corp dated November 15, 2019 (MJ Holdings, Inc., Filed With SEC on December 10, 2020)
*** Certain identified information hasbeen omitted from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Registrantif publicly... (Adamis Pharmaceuticals Corp, Filed With SEC on August 17, 2020)
Termination Agreement, dated (Amag Pharmaceuticals, Filed With SEC on July 27, 2020)
Termination of Employment Agreement and Release, dated as of March 22, 2020, by and between Foamix Pharmaceuticals Ltd. and Ilan Hadar (Menlo Therapeutics Inc., Filed With SEC on May 11, 2020)
Termination and Release Agreement, by and among Cronos Group Inc. and William Lawrence Hilson, dated as of November 15, 2019 (Cronos Group Inc., Filed With SEC on March 2, 2020)
Termination and Release Agreement, by and among Cronos Group Inc. and David Hsu, dated as of November 15, 2019 (Cronos Group Inc., Filed With SEC on March 2, 2020)
Termination Agreement, effective December 31, 2019, by and between Svend Andersen and Wrafton Laboratories Limited (Perrigo, Filed With SEC on February 27, 2020)
Termination Agreement among Trava LLC, the Company, EWSD I LLC, and Pueblo Agriculture Supply and Equipment LLC, dated January 29, 2018 (Notis Global, Inc., Filed With SEC on November 27, 2019)
Termination Agreement, by and between the Registrant and Aventis, Inc. dated July 17, 2019 (MyoKardia Inc, Filed With SEC on November 4, 2019)
Termination of Distribution and Supply Agreement, dated as of August 6, 2019, by and between AMAG Pharmaceuticals, Inc. and Prasco, LLC (Amag Pharmaceuticals, Filed With SEC on November 1, 2019)